Promise of Quantitative Proteomics in the Qualification of New Approach Methodologies

Fuente: Wiley Open Access
Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Bhagwat Prasad
Format: Artículo Open Access
Veröffentlicht: Wiley 2025
Schlagworte:
Online-Zugang:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
_version_ 1867002194026299393
author Bhagwat Prasad
author_facet Bhagwat Prasad
Bhagwat Prasad
collection Wiley Open Access
contents Promise of Quantitative Proteomics in the Qualification of New Approach Methodologies Bhagwat Prasad Clinical Pharmacology & Therapeutics The shift from animal models to new approach methodologies (NAMs) in drug development requires experimental models that accurately reflect human biology. Characterizing protein abundance and composition in NAMs like microphysiological systems (MPS), enabling comparison with human tissues, allows identification of physiological differences, development of scaling factors for in silico models, monitoring of biomarkers, cellular heterogeneity, and interindividual variability. Thus, characterization of NAMs by quantitative proteomics is important for enhancing their translational and regulatory relevance. 10.1002/cpt.70049 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/cpt.70049
format Artículo Open Access
id wiley_oa_10_1002_cpt_70049
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2025
publisher Wiley
record_format wiley_oa
spellingShingle Promise of Quantitative Proteomics in the Qualification of New Approach Methodologies
Bhagwat Prasad
Clinical Pharmacology & Therapeutics
Promise of Quantitative Proteomics in the Qualification of New Approach Methodologies Bhagwat Prasad Clinical Pharmacology & Therapeutics The shift from animal models to new approach methodologies (NAMs) in drug development requires experimental models that accurately reflect human biology. Characterizing protein abundance and composition in NAMs like microphysiological systems (MPS), enabling comparison with human tissues, allows identification of physiological differences, development of scaling factors for in silico models, monitoring of biomarkers, cellular heterogeneity, and interindividual variability. Thus, characterization of NAMs by quantitative proteomics is important for enhancing their translational and regulatory relevance. 10.1002/cpt.70049 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Promise of Quantitative Proteomics in the Qualification of New Approach Methodologies
topic Clinical Pharmacology & Therapeutics
url https://ascpt.onlinelibrary.wiley.com/doi/10.1002/cpt.70049